XTL Biopharmaceuticals receives additional Nasdaq delist notice May 22, 2026 04:11PM
XTL Biopharmaceuticals changes ADS ratio effective March 25 Mar 20, 2026 04:10PM
XTL Biopharmaceuticals receives Nasdaq delisting notice Feb 27, 2026 04:31PM
XTL Biopharmaceuticals receives NASDAQ delisting warning Jan 23, 2026 04:10PM
XTL Biopharmaceuticals acquires 85% stake in NeuroNOS for autism therapeutics Jan 13, 2026 09:28AM


Jan 13, 2026 07:31AM XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary
Apr 7, 2025 09:15AM XTL Biopharma (XTLB) Appoints Noam Band as CEO
Aug 14, 2024 09:15AM XTL Biopharma (XTLB) Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million